C9 Antibody (Monoclonal)

A murine monoclonal antibody to an epitope on C9.

Product Specifications

Citations 3
Clonality

Monoclonal
Immunogen Purified human protein.
Applications See citations and technical data sheet for application info.
Concentration 1.0-1.2 mg/mL
Conjugate Unconjugated
Cross Reactivity

Human, Baboon, Bovine, Chicken, Guinea pig, Hamster, Horse
Technical Documents

Ordering Information

For Research Use Only in the United States. Not for use in diagnostic procedures.
Catalog Number A223
Catalog Number (CE) N/A
Size 100 µl
Price (USD) $365.00
Price (EURO) 330,00 €
Request an Order

Contact us

US Phone+1 (858) 552 1100
EU Phone+353 (91) 412 474
US Emailcontact-us@quidelortho.com
EU Emailcontact-emea@quidelortho.com

Specifications

Description

A murine monoclonal antibody to an epitope on C9.
Size 100 µl
Concentration

1.0-1.2 mg/mL

Applications See citations and technical data sheet for application info.
Form Liquid. Borate Buffered Saline (pH 8.4 ± 0.2), with ≤ 0.1% Sodium Azide.
Clonality Monoclonal
Immunogen Purified human protein.
Conjugate Unconjugated
Cross Reactivity Human, Baboon, Bovine, Chicken, Guinea pig, Hamster, Horse
Isotype IgG2bk
Purity ≥ 95% by SDS PAGE
Source

Mouse
Specificity This monoclonal antibody was raised against purified human C9. It is specific for an antigen expressed on the C9 but not expressed in MAC. It will inhibit the lysis of EA and will not bind to membrane associated MAC.
Storage

Short term (30 days) 4˚C. Long term at or below –20˚C.
Background

Complement protein, C9 is a single-chain glycoprotein with a molecular weight of 71 kD. The C9 protein is present in serum at a concentration of approximately 55 μg/ml. Upon activation of the Classical, Lectin or Alternative Complement Pathways, C9 becomes integrated into the Terminal Complement Complex (TCC). The Terminal Complement Complex (TCC) is the general term for both membrane bound C5b-9 (or Membrane Attack Complex; MAC) and fluid phase SC5b-9. Assessment of the TCC is an excellent marker for qualifying the extent of Terminal Pathway activation in vivo or in vitro. TCC can be deposited on the surface of transformed cells, biomaterials, and a variety of other surfaces.

Citations

Certificate of Analysis

Showing results for
No results found for